Hyperuricemia on Hypertension and Metabolic Syndrome
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the influence of hyperuricemia treatment compared
with placebo on participants with high risk of hypertension and metabolic syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Collaborator:
National Council of Science and Technology, Mexico